Antengene
Shanghai
About Antengene
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research and drug production, enabling physicians to meet unmet medical needs in Asia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $238.0M
- Funding stage: IPO
- Last round: Series C (Jul 2020)
- Ticker: hkg:6996
- Website: antengene.com
- Phone: +86 21 3250 1095
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/antengene-130510 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.